ISRCTN89304265已完成不适用
Glutathione status in platelets from patients with Type 2 Diabetes: therapeutic potential of N-Acetylcysteine (NAC) to help prevent platelet hyperaggregability, a double-blind placebo-controlled randomized crossover study
HS Highland Health Board (United Kingdom)0 个研究点目标入组 44 人开始时间: 2011年5月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adult type-2 diabetes patients (men or post-menopausal women)
- •2. Either not receiving (group A) or receiving (group B) aspirin
排除标准
- •1. Glycated haemoglobin (HbA1c) greater than 10%
- •2. Random triglyceride greater than 4 mmol L-1
- •3. Creatinine > 150 ?Ýmol L-1
- •4. Current or recently stopped (less than 6 months) smoking
- •5. Receiving other antiplatelet therapy or lipid lowering therapy
- •6. Asthma sufferer
- •7. Current use of tetracycline or cough suppressants
研究者
相似试验
进行中（未招募）
不适用
Glutathione Status in Platelets From Patients With Type 2 Diabetes: Therapeutic Potential of N-acetylcysteine to Help Prevent Platelet Hyperaggregability - NAC studyPlatelet Aggregation in type 2 diabetesEUCTR2008-001620-31-GBHS Highland44
已完成
不适用
Platelet analysis in patients with haematological diseases with increased risk of thrombosis and bleedingbleedingthrombosis1001886510014523NL-OMON55308Catharina-ziekenhuis102
招募中
不适用
A study of the levels of the enzyme glutathione-s-transferase in patients receiving intravenous paracetamol during and after surgeryCTRI/2015/10/006307JIPMER60
已完成
不适用
Platelet rEactivity in patieNts with DrUg eLUting stent and balancing risk of bleeding and ischeMic eventPatients with ACS or elective indications undergoing PCI with drug-eluting stent implantation.JPRN-UMIN000020332Toho University Ohashi Medical Center6,422
尚未招募
Unknown
Immature platelet fraction in patients infected with COVID-19CTRI/2023/12/060412Rashmi Jain Gupta